Senvest Management’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
SCM
PIM
FWSM
HAIM
2L
HA
LAM
Senvest Management's TRIB Position: Q4 2018 in Review
Senvest Management sold out of Trinity Biotech (TRIB) in Q4 2018, closing a stake of 6,693 shares — an estimated $4.02M sold.
Senvest Management first reported a position in TRIB in Q4 2014 and held it in 16 quarters. The position peaked at $9.9M in Q2 2015. 40 funds tracked by Wall St. Rank hold TRIB as of Q4 2018.
- Senvest Management reported no remaining Trinity Biotech position as of Q4 2018 after selling out during the quarter.
- Senvest Management sold 6,693 Trinity Biotech shares in Q4 2018, an estimated $4.02M.
- Senvest Management first reported a position in Trinity Biotech in Q4 2014 and held it in 16 quarters.
- Senvest Management's Trinity Biotech position peaked at $9.9M in Q2 2015.
- 40 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2018.
Based on Senvest Management's 13F filing for Q4 2018, filed 14 Feb 2019.